A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.
Clinical trial NCT01195272 · COMPLETED
Trial details
- NCT number
- NCT01195272
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2012-03-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.